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Breast Cancer Cell Invasion into a 
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Mehdi Nikkhah1
In this study, to model 3D chemotactic tumor-stroma invasion in vitro, we developed an innovative 
microfluidic chip allowing side-by-side positioning of 3D hydrogel-based matrices. We were able to (1) 
create a dual matrix architecture that extended in a continuous manner, thus allowing invasion from 
one 3D matrix to another, and (2) establish distinct regions of tumor and stroma cell/ECM compositions, 
with a clearly demarcated tumor invasion front, thus allowing us to quantitatively analyze progression 
of cancer cells into the stroma at a tissue or single-cell level. We showed significantly enhanced cancer 
cell invasion in response to a transient gradient of epidermal growth factor (EGF). 3D tracking at the 
single-cell level displayed increased migration speed and persistence. Subsequently, we analyzed 
changes in expression of EGF receptors, cell aspect ratio, and protrusive activity. These findings show 
the unique ability of our model to quantitatively analyze 3D chemotactic invasion, both globally by 
tracking the progression of the invasion front, and at the single-cell level by examining changes in 
cellular behavior and morphology using high-resolution imaging. Taken together, we have shown a 
novel model recapitulating 3D tumor-stroma interactions for studies of real-time cell invasion and 
morphological changes within a single platform.
Breast cancer is the one of leading causes of cancer-related death among women in the United States1. This disease 
progresses in many steps ranging from tumor growth, stroma invasion, and spreading throughout the body2,3. 
Invasion into the surrounding stroma begins a process of interactions between tumor cells and the stroma by 
cellular crosstalk and paracrine signaling (i.e. fibroblasts, pericytes, immune cells, endothelial cells, etc.) and is 
influenced by biochemical/biophysical cues (i.e. drug and nutrient transport, ECM composition and stiffness, 
etc.) within the stroma2,4–6. Despite significant advances in therapeutic regimens, anti-cancer drugs often fail 
due to lack of comprehensive preclinical studies utilizing models incorporating the complexities of the native 
tumor-stroma microenvironment7–11. In this regard, the interactions that specifically arise from a variety of bio-
chemical and biophysical gradients, and cellular components should not be overlooked when developing in vitro 
tumor microenvironment models12.
Chemoattractants, such as epidermal growth factor (EGF), are aggressive drivers of cancer invasion by acti-
vating cell membrane receptors and intracellular pathways that provide guidance and motility cues to the cells3. 
For example, cancer cells have been shown to secrete colony stimulating factor-1 (CSF-1), which then causes 
macrophages to produce gradients of EGF13,14. This would often lead to enhanced proliferation, survival, and 
motility of cancer cells15–18. For example, micro-needles filled with Matrigel® and EGF inserted into the mouse fat 
pads attracted breast cancer cells to the site of injection. However, this model required expensive imaging, such as 
multiphoton laser-scanning and second harmonic generation19,20, to observe the effect of EGF on cancer invasion 
in real-time18. Furthermore, animal models do not allow decoupled control of cell-cell and cell-ECM interactions 
creating significant difficulties in elucidating the role of each separate stromal component. For instance, cancer 
cells in vivo have been shown to migrate toward one specific areas of vascularization. However, it was unclear 
whether the cancer cell’s response was due to the sole role of biochemical (i.e. chemoattractants) or biophysical 
(i.e. interstitial flow or collagen stiffness) gradients21. Moreover, stromal cells, such as macrophages or fibroblasts, 
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localized to specific regions within the tumor microenvironment can generate interfering signaling cues and 
chemoattractant gradients, which make it especially challenging, to elucidate the sources that trigger cancer cell 
invasion22–24.
Conventional in vitro 2D assays have been extensively used to assess the role of chemoattractants on can-
cer cell migration25,26. Wang et al. utilized a 2D platform simplifying the tumor microenvironment to only a 
monolayer of cells. They demonstrated that breast adenocarcinoma cell line (MDA-MB-231) migrated on 2D 
surfaces towards higher concentrations of EGF with varying speeds25. Although the findings were significant, the 
2D model utilized in this study did not recapitulate the organization of tumor-stroma and ECM heterogeneity, 
normally found within the native tumor microenvironment. Most importantly, the lack of encapsulated cells 
within 3D ECM-based matrices, which are representative of cancer invasion within the stroma, could influence 
the biological findings27.
Traditional 3D systems currently used in invasion studies, such as Boyden chambers and Transwell migra-
tion assays, lack the ability to precisely control the spatial organization of cells in 3D matrices, cell-cell as well 
as cell-ECM interactions. To that end, microfluidic platforms have shown significant promise to study different 
aspects of cancer through better recapitulation and direct control over distinct components (i.e. cells, ECM, solu-
ble factors) within the tumor microenvironment28. These recent innovations have enabled the capture of different 
facets of metastasis such as biochemical signaling29, tumor-stroma interactions30, invasion31,32, intravasation33, 
and extravasation34,35. Despite significant progress, most of the previous findings have relied on models with sim-
plified or no compartmentalization of 3D interconnected tumor and stroma regions to precisely control spatial 
cell-cell and cell-ECM interactions. For example, some models that seeded cancer cells on 2D channels lacked the 
physiologically relevant influence of the 3D matrices33,35,36. There are also microfluidic devices that have demon-
strated cell migration within 3D hydrogels31,32, but they were missing incorporation of tumor-stroma entities, 
thus having only a single compartment for cancer cell encapsulation. These limitations reduced their ability to 
study cancer invasion through side-by-side heterogeneous ECM, organized co- or tri-culture of cells as well as 
transport of growth factors and nutrients through diffusive barriers (i.e. solid tumors). Apart from technological 
development, these models often have been limited by the lack of 3D real-time single cell migration analysis from 
the tumor toward the stroma region during active invasion. Alternatively, models that compartmentalized cells 
into separated 3D stroma and tumor regions were not specifically intended to demonstrate real-time 3D inva-
sion studies and enable modulation of microenvironmental cues (e.g. biophysical and biochemical signaling). 
Moreover, these platforms did not contain perfusable channels surrounding the tumor-stroma regions to assess 
the influence of chemotactic gradients on cancer cell invasion30,37.
In this study, we have developed a new microfluidic cancer invasion platform capable of spatially organizing 
3D cell-embedded hydrogel matrices while enabling real-time capture of 3D cancer invasion within heteroge-
neous ECMs. The microengineered platform was designed to introduce 3D interconnected tumor and stroma 
regions with different ECM and cell compositions. This approach primarily provides an advantage over 2D 
platforms by facilitating the study of cellular migration within a native-like 3D tumor microenvironment using 
hydrogel-based matrices. Moreover, an important feature of our design allows the capture of an ECM-embedded 
high-density cell population (~15 million cells/mL) that better mimics a 3D solid tumor with dynamic diffu-
sion of soluble factors and paracrine signaling not possible in 2D platforms38. On the other hand, when com-
pared to previously established 3D platforms30,31,33, our model contains a specific tumor region surrounded by 
a separate ECM-filled entity (stromal region) permitting a juxtaposition of different ECM or cell mixtures (e.g. 
cancer-associated fibroblasts (CAFs)) to recapitulate cancer invasion throughout a heterogeneous tumor-stroma 
microenvironment. We utilized the proposed model to specifically assess how exposure to EGF impacts 3D can-
cer cell invasion through the stroma. In addition, the proposed design enabled generation of differential microen-
vironments, due to the presence of two separated channels, to specifically assess the effect of distinct gradients of 
EGF on cancer cell invasion. We took advantage of our device to visualize and quantify 3D cell migration metrics 
and morphology, utilizing advanced microscopy techniques, at both a global and single-cell level. As a result, we 
noted enhanced cell speed and persistence in the presence of EGF along with increased levels of cell proliferation 
and clustering of EGF receptors (EGFRs) indicative of cells responding to EGF. Furthermore, we correlated the 
enhanced invasiveness to cell morphology changes such as increased aspect ratio and number of protrusions. 
Overall, this work underscores a technical advance that was designed to recapitulate invasion of cancer cells in 
adjacent tumor and stroma regions of different ECM and cell compositions within a microengineered platform. 
This will allow future studies to assess the influence of various combinations of cell-cell and cell-ECM interactions 
on cancer invasion in a well-controlled experimental condition.
Results
Development of the 3D Spatially Organized Cancer Invasion Platform. Motivated by the need 
to simulate the invasion of cancer cells from the primary ‘tumor’ into the enclosing stroma, a microfluidic plat-
form was designed to organize the cancer cells into a central tumor region surrounded by a stroma entity39,40. 
The microfluidic device specifically consisted of an inner chamber (tumor region) bordered by an outer cham-
ber (stromal region) (Fig. 1A) to produce a side-by-side arrangement of 3D matrices. The diameter and height 
of these concentric chambers were 3 mm and 200 μ m, respectively. The distance between the edge of the inner 
chamber and outer chamber was 1 mm. Both of these chambers were bounded by trapezoidal micro-posts spaced 
evenly at 100 μ m to create a concentric spatial organization with clear interfaces while allowing interaction 
between the different regions. The trapezoid shape was chosen to permit uniform gel formation between the 
posts due to the angle of the trapezoid being supplementary to the contact angle of the gel solution and PDMS41,42. 
Tumor cells were encapsulated within a hydrogel solution and loaded first into the device through the central cell 
filling port (Fig. 1B and Supplementary Fig. S1). The stromal region was then loaded with cell-free hydrogel to 
produce an interconnected platform. The platform had two inputs that can be filled with cell media containing a 
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variety of molecules (e.g., EGF) to enhance or suppress cancer invasion. Additionally, the design of the platform 
enabled creating symmetric and asymmetric gradients of biomolecules. Compared to 2D models25,26 and other 
conventional 3D models31,33,38, this assay particularly allowed for control over 3D spatial compartmentalization 
of cells, ECM heterogeneity, and biomolecular gradients.
To demonstrate the formation of a clear-cut spatial arrangement of ECM, we first utilized fluorescent-labeled 
hydrogels. Rhodamine-6G hydrogel solution was loaded into the tumor region followed by a fluorescein hydrogel 
solution loaded into the stromal region. After gelation, the formation of the hydrogels within specific regions of 
the platform was visualized under a fluorescent microscope (Fig. 1C). There were no gaps between the posts that 
could disrupt the interconnectivity of the two side-by-side regions, and the trapezoidal posts held the gels in place 
while also separating the inner and outer chambers. In that regard, the interconnectivity of the regions within 
the platform enabled signaling from the channels to the stroma to the tumor. Next, to demonstrate cell-ECM 
spatial organization, SUM-159 breast cancer cells were encapsulated within a collagen I matrix and loaded into 
the tumor region while cell-free collagen I was loaded into the stromal region. Following successful gelation of the 
hydrogels, carcinoma cells were present only within the tumor region while leaving the stroma pristine (Fig. 1D). 
Additionally, no gaps or bubbles were present between the tumor and stroma and the cells were distributed in 
3D (Supplementary Fig. S2). The spatially organized tumor-stroma potentially allows for further studies utilizing 
different cell types and/or different ECM compositions, which will provide insight and understanding into how 
other cell types and environments influence cancer invasion9.
Characterization of Diffusion Across the Platform. COMSOL simulation of EGF diffusion was used 
to characterize the time-dependent gradient during chemoinvasion within the platform. Diffusion of 10 kDa 
molecules was simulated within a 3D collagen I gel (2.0 mg/mL) at 37 °C. Figure 2A demonstrates the computed 
time-lapse of the concentration gradient across the tumor-stroma microenvironment. In addition, Fig. 2B shows 
the simulated concentration profile within the device. To experimentally demonstrate diffusion across the plat-
form and show that the regions within the device were well interconnected, 10 kDa FITC-Dextran (10 μ g/mL) 
was injected into the media inlets and the resulting fluorescent intensity across the platform was recorded over 
time. By 30 min (Fig. 2C), the fluorescent dextran had continuously diffused across the stroma and into the tumor 
region, demonstrating that the interface between the two regions enabled diffusion of biomolecules from one 
region to the other while showing an established concentration gradient. Figure 2D provides the quantified exper-
imental results for the concentration gradient profile showing similarities to the simulated gradient profile up to 
2 h (Fig. 2B). Differences between the experiments and simulation likely arise from small convective flows gener-
ated during media changes. A gradient was established for up to 2 h and leveled out afterwards. This suggests that 
there is an optimum window to replenish the media at this time but other factors that can perturb the gradient 
profile are also in play such as cell-ECM interactions and cell-biochemical cue (i.e. the diffused cues) interactions.
Cell Behavior within a Physiologically Relevant 3D Microenvironment. To represent the inva-
sive tumor microenvironment, SUM-159 breast carcinoma cells were to initially encapsulated at a high density 
(15 × 106 cells/mL) within three distinct matrices namely, Matrigel® , collagen I (2 mg/mL), and 1:1 mixture of 
Matrigel® and collagen I (final concentration of collagen I at 1 mg/mL) and were subsequently loaded into the 
tumor region. The stroma region was kept constant for all conditions by only loading the outer chamber with 
Figure 1. Spatial-organization of ECM and cells. (A) The tumor region is represented by the red color and the 
stroma is represented by the green. The depth of the channels is 200 μ m. (B) Spatial-organization of cells and/or 
ECM is performed in a two-step process. Cancer cells were encapsulated in a tumor matrix and injected into the 
tumor filling port. The matrix was polymerized and then the stroma matrix was injected into the stromal filling 
port. This matrix was then polymerized and the final result is a tumor surrounded by a stroma. (C) Fluorescent 
image demonstrating ECM compartmentalization. A red hydrogel was injected into the tumor region while a 
green gel was injected into the stroma (scale bar: 200 μ m). (D) Phase-contrast image of cells isolated within the 
tumor region while a cell-free stroma hydrogel surrounds it (scale bar: 200 μ m).
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collagen I (2 mg/mL), which is the most abundant ECM protein outside the primary breast tumor area19,20. Initial 
studies revealed that the SUM-159 cells that were encapsulated within the Matrigel® matrix demonstrated a 
mixture of round and elongated morphology after one day of culture (Fig. 3A). As the cells migrated out from 
the tumor region and into the collagen matrix of the stroma, they began to adopt more elongated morphol-
ogy representative of an invasive phenotype30. On the other hand, breast carcinoma cells that were still within 
the tumor region (Matrigel® ) maintained their roundness. SUM-159 that were encapsulated within collagen I 
(2 mg/mL) matrix also exhibited a mixture of round cells and elongated cells after one day of culture (Fig. 3B). 
However, by the third day within the collagen-only tumor region, there were little to no round cells (Fig. 3B), 
whereas the Matrigel® -only matrix still had round cells by day 3 (Fig. 3A). Although the cells encapsulated in 
either collagen I or Matrigel® were able to successfully migrate out of the tumor region, there were significant 
matrix disruptions. The disruptions near the microposts created gaps within the matrix that would have pre-
vented cells from traversing through the 3D microenvironment. To prevent the gap formation so that the cells 
may continuously invade from the tumor into the stroma while maintaining a physiologically relevant platform, 
Matrigel® and collagen I (2 mg/mL) were mixed at a ratio of 1:1 prior to cell encapsulation. As seen in Fig. 3C, 
cells demonstrated a mixture of round and elongated morphology within the mixed gel that was similar to the 
previous two matrices (Fig. 3A,B) demonstrating the continuous invasion. By the third day, the cells invaded into 
the stroma without disruption of the matrix in contrast to the previous two conditions (Fig. 3A,B). Additionally, 
unlike the collagen-only hydrogel, there were still round and elongated cells within the tumor region on day 3, 
which demonstrated similar morphology to the Matrigel® -only matrix. Thus the mixed gel was chosen for all 
subsequent experiments to represent a more physiologically relevant primary tumor region38, while still allowing 
cells to continuously invade throughout the platform with little matrix disruption. This potential to decouple and 
modulate the tumor and stroma characteristics could allow further studies to develop stiffness and ligand-density 
gradients to elucidate the effects of haptotactic and biophysical cues on invasion dynamics.
To investigate the survival of the breast cancer cells within the mixed gel (Matrigel® :collagen I) microenvi-
ronment, the encapsulated cells were stained with the LIVE/DEAD assay at days 1 and 3. The live cells, which 
fluoresced green, and the dead cells, which fluoresced red, were counted and compared between the two days 
(Fig. 3D). The viability was quantified to be 90.3 ± 3.44% and 91.7 ± 0.88% for days 1 and 3 respectively and no 
statistical difference over the three days. These results suggested that the encapsulation of the cells within the 
mixed gel did not create a significant impact on cell survival.
Tumor Growth and Dissemination of Invasive Breast Cancer Cells. To understand the effects of 
EGF on the invasion of the SUM-159 within the spatially organized microenvironment, medium containing 
EGF (50 ng/mL) was added to the platform daily after an initial 24 h culturing period. The stimulated ((+ ) EGF) 
and unstimulated ((− ) EGF) cells were tracked for a total of four days (96 h). During the first 24 h (Day 0), the 
cells adopted round morphologies and were contained within the tumor region (Fig. 4A). After one day, the cells 
began to invade into the stroma with a mixture of round and elongated morphologies. Cells were distributed 
spatially similarly between the two EGF conditions (Fig. 4B). By day 3 there was a significant difference in tumor 
Figure 2. Diffusion of molecules through the two regions. (A,B) COMSOL simulation of 10 kDa molecule 
(10 μ g/mL) through the device demonstrates the concentration gradient profile over time. (C) FITC-
Dextran (10 kDa, 10 μ g/mL) was diffused from the stroma to the tumor region to demonstrate successful 
interconnectivity and concentration gradient between the two regions (scale bar: 100 μ m). (D) Quantified 
experimental results of diffusion of FITC-Dextran (10 kDa, 10 μ g/mL).
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dissemination when comparing the stimulated (715 ± 38.0 μ m) and unstimulated conditions (556 ± 24.7 μ m), 
demonstrated by a rightward distribution shift by (+ ) EGF cells along the x-axis (Fig. 4B). We also calculated the 
progress of the tumor invasion front over the four day period for both conditions and found that by days 3 and 4, 
the (+ ) EGF tumor invaded further than (− ) EGF (Fig. 4C). The invading distance of furthest distal cells from the 
microposts (Fig. 4C) were compared daily demonstrating that by days 3 and 4, the (+ ) EGF tumor invaded fur-
ther than (− ) EGF. Moreover, whole device images taken of the actin cytoskeleton (Supplementary Fig. S3) dis-
played the stark difference between the two conditions in terms of tumor growth and cell invasion. The stimulated 
cells migrated beyond the stroma and into channels by day 4. In addition, we compared the migration of invasive 
Figure 3. Behavior of breast cancer cells within different ECMs. (A) SUM-159 breast cancer cells were 
initially encapsulated in Matrigel® . On the first day, the cells demonstrated round morphology and by the third 
day, the matrix was disrupted (scale bar: 100 μ m). (B) Collagen I (2.0 mg/mL) was utilized to encapsulate cells 
within the tumor region. The cells demonstrated similar morphology to Matrigel® on the first day. On day 3, 
cells migrated outside of the tumor region but also exhibited great disruption of the ECM, similarly to Matrigel® 
(scale bar: 100 μ m). (C) A mixed gel of Matrigel® :collagen I (1:1 ratio) was utilized to reduce matrix disruptions. 
By day 3, the cells successfully migrated out but did not disrupt the tumor as heavily (scale bar: 100 μ m). (D) 
LIVE/DEAD was utilized to assess the viability of the cells on day 1 and 4 within the mixed gel. The cells were 
highly viable and did not demonstrate any significant change between the two days (p < 0.05 calculated from 
Student’s t-test with more than three devices for each condition, scale bar: 100 μ m).
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SUM-159 breast cancer cells to the less invasive MCF-7 cell line within our platform. MCF-7 cells developed into 
clusters of cells near the edge of the tumor region (Supplementary Fig. S4A). EGF stimulation enhanced invasion 
of MCF-7 cells into the stroma (80 ± 8 μ m) compared to the control condition without EGF (20 ± 2 μ m) on day 2 
(Supplementary Fig. S4B). However, when comparing to SUM-159 cells, MCF-7 invasion in presence of EGF was 
significantly lower by almost 10-fold within each day of the experiment (Supplementary Fig. S4C). We also inves-
tigated the effect of EGF on proliferation of SUM-159 cells by quantifying the number of cells within the stromal 
region which revealed increased cell count in the presence of EGF stimulation from day 0 to day 3 (Fig. 4D and 
Supplementary Fig. S5A). Moreover, in the (+ ) EGF condition expression of the proliferative marker, Ki-67, was 
increased (Supplementary Fig. S5B). These findings demonstrated that EGF enhances breast cancer cell invasion 
within the microengineered 3D platform, consistent with previous studies using 2D assays25.
In addition to global diffusion through the platform from both media channels, we introduced EGF (50 ng/mL) 
to a single media channel to localize the chemoattractants asymmetrically through half of the device (Fig. 5A). 
The cells were consistently tracked for four days (96 h) (Fig. 5B). We observed no differences in cell migration 
during the first 24 h of culture. However, by day 2 there was a significant increase in invasion toward the channel 
in which we introduced EGF (Fig. 5C). Such trend was consistent during days 3 and 4. In fact, by day 4, there were 
cells that had migrated out of the stroma and into the media channels on the EGF side, however, such behavior 
was not observed on the other side of the stroma (the media only side channel with no EGF (Fig. 5B)). These 
observations clearly demonstrate the capability of our microfluidic platform to generate competing microenvi-
ronments (Fig. 5C) through introduction of variable regimes of growth factors for invasion studies.
High Resolution Real-time Imaging of Three-dimensional Cancer Invasion at a Single-cell 
Level. In comparison to previous real-time migration studies31,43, our model and technique enabled us to 
observe the changing morphology of the invading cancer cells at a single-cell level within the 3D matrices, at a 
high-resolution, using light and fluorescent microscopy. In particular, cells migrated by utilizing thin protrusions 
probing in front of their cell body and moving their body toward the direction of the protrusions (Fig. 6A and 
Figure 4. Breast cancer 3D invasion assay. (A) Devices were split into two groups where one group (+ EGF) 
was introduced to EGF (50 ng/mL) and the other was not exposed to EGF (− EGF). Based on the representative 
images, (+ ) EGF showed more proliferation, as indicated by the higher density, and migration by reaching 
to the outer channels in 4 days. The (− ) EGF group demonstrated migratory tendencies but did not have the 
same invasive profile as (+ ) EGF. (B) Distribution of cells was quantified for days 1 and 3. The profiles were 
similar between (− ) and (+ ) EGF for the first day. By the third day, there was a shift in cell distribution toward 
the right indicating a higher cell count further away from the tumor region. It was not possible to quantify the 
distribution for the fourth day due to the high density and overlapping cells (scale bar: 100 μ m). (C) Invasion 
distance of the tumor front was calculated from the radial distances of the furthest cells from the tumor region. 
(+ ) EGF exhibited significantly higher invasion by days 3 and 4 (p < 0.05 calculated from Student’s t-test with 
more than three devices for each condition). (D) Number of cells of cells was quantified on days 1 to 3 with (+ )  
EGF leading to a significantly higher cell count (p < 0.05 calculated from Student’s t-test with more than three 
devices for each condition).
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Supplementary Movies S1 and S2). Furthermore, these cells appeared to drag their bodies along as the protrusive 
front moves forward. Using 3D time-lapse imaging (Supplementary Movie S3), we tracked individual cells, which 
was further analyzed in NIS Elements AR Microscope Imaging Software by Nikon, to investigate the effects of 
EGF on 3D tumor cell migration within the initial 24 h of adding EGF (Fig. 6B). We found a significant increase in 
average individual cell speed (Fig. 6C) (0.16 ± 0.006 μm/min) compared to the (− ) EGF (0.14 ± 0.006 μm/min) 
condition. Moreover, we did not see a significant difference in the persistence (Fig. 6D) for (+ ) and (− ) EGF at 
0.32 ± 0.01 and 0.29 ± 0.01 respectively. However, when observing the cell trajectory plots (Fig. 6B), we noticed 
migration differences between the cells along the gradient (Fig. 2), where there were increased cell counts near the 
y-axis (Fig. 6B, within the pie slice). To investigate this phenomenon, we filtered the cells to only those migrating 
within ± 30° of the gradient (y-axis) in order to isolate the sub-population of cells based on the diffusion gradient 
(Fig. 6A) and subsequently compare the average speed and persistence. In doing so, we found that the average 
speed among filtered cells was still significantly higher for (+ ) EGF (0.23 ± 0.02 μm/min) compared to (− ) EGF 
(0.17 ± 0.02 μm/min). Furthermore, persistence within the filtered cells was found to be significantly higher for 
(+ ) EGF (0.52 ± 0.03) than (− ) EGF (0.36 ± 0.03). We continued to culture the cells for two more days with daily 
media exchanges. The experiment was repeated again between 72 h and 96 h of culture (Fig. 7A). Consistently, we 
found a significant increase in average speed of individual cells (Fig. 7B) for (+ ) EGF (0.14 ± 0.005 μm/min) com-
pared to (− ) EGF (0.11 ± 0.005 μm/min) suggesting that EGF maintained high cell motility over prolonged expo-
sure. Moreover, we noticed a significant difference in the persistence (Fig. 7C) for (+ ) and (− ) EGF at 0.40 ± 0.02 
and 0.29 ± 0.02 respectively. When looking at the filtered cells (Fig. 7D), we still found that the average speed 
was significantly higher for (+ ) EGF at 0.13 ± 0.009 μm/min whereas (− ) EGF demonstrated 0.10 ± 0.006 μm/
min. However, the difference in persistence among the filtered cells (Fig. 7E) was not found to be significant 
(0.60 ± 0.03 vs. 0.51 ± 0.05) suggesting cells behaving in more of a random walk fashion, at longer duration of 
culture, as compared to the initial 24 h of EGF stimulation.
Analysis of EGF Receptors After Long-Term Stimulation. We stained the cells for EGFRs and phos-
phorylated EGFRs (pEGFRs) after 1, 2, and 4 days of culture in order to visualize the patterning and activation 
of EGFRs in response to EGF stimulation within the device. On the first day of culture on both a 2D surface and 
within the hydrogel matrices (no EGF), EGFRs localized near the cell membrane (Supplementary Fig. S6A). 
After treatment with EGF for 24 h (Day 2 of culture, Supplementary Fig. S6B), we noticed that in the (+ ) EGF 
condition, EGFRs began to displace from the membrane toward the cell body and the distribution became more 
punctate44,45. In the (− ) EGF condition (Day 2), the location of the EGFRs remained similar to the receptors in 
Day 1 images (Supplementary Fig. S6B). However, after 4 days, EGFRs no longer bordered the cell membrane, 
unlike the first days of culture (Supplementary Fig. S6B). Moreover, the receptors appeared in a punctate pat-
tern throughout the cell body for both (± ) EGF conditions (Fig. 8A). On the other hand, the pEGFR staining 
demonstrated higher intensity and a greater number of spots in the (+ ) EGF condition compared to the (− ) EGF 
samples. As can be also seen in Fig. 8B, heat maps of relative surface intensity displayed high clustering of the 
EGFRs near the nucleus in (+ ) EGF condition while EGFRs were seen to be distributed through the cell body in 
(− ) EGFs condition. We normalized the EGFR coverage area to the area of the cell body using actin as a marker 
for total cell area on Day 4. The EGFR to cell area ratio (Fig. 8C) was significantly higher in the (− ) EGF group 
consistent with the clustered or localized EGFRs in (+ ) EGF condition suggestive of EGFR trafficking. On the 
other hand, the pEGFR to cell area ratio (Fig. 8D) was significantly higher in the (+ ) EGF group. Furthermore, for 
the (+ ) EGF group (Fig. 8E), we found a significantly higher pEGFR to EGFR area ratio suggesting more phos-
phorylated receptors among the available receptors. Overall, our findings suggest that the migratory phenotype 
of breast cancer cells, is linked to the activation of EGFRs and further demonstrates successful delivery of EGF to 
the cells within the 3D microfluidic device.
Cytoskeleton Organization of Invasive Cells. We investigated the changes in the cytoskeleton due to 
EGF-induced invasion. Upon close inspection we found that (− ) EGF cells were not as spread as the cells within 
Figure 5. Breast cancer 3D invasion assay using asymmetric gradients. (A) COMSOL simulation
(24 h) of 10 kDa molecule (10 μg/mL) from a single channel through the device demonstrates the concentration
gradient. (B) EGF (50 ng/mL) to a single channel while the other contained no supplemented EGF media. 
We found increased cell gravitation toward the side with EGF (C) Invasion distance of the tumor front was 
calculated from the radial distances of the furthest cells from the tumor region. (+ ) EGF exhibited significantly 
higher invasion by days 2, 3, and 4 (p < 0.05 calculated from Student’s t-test with more than three devices for 
each condition).
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the EGF-stimulated devices. As seen in the Z-projection of the F-actin (Fig. 9A), more round cells, indicated 
by the white arrows, were apparent in the (− ) EGF group. The actin area, which delineates the area of the cell, 
(Fig. 9B) was calculated by thresholding the fluorescent images and dividing the total actin area by the number 
of cells present in the field of view. This revealed that (+ ) EGF cells had almost twice the actin area than (− ) EGF 
cells, which is representative of the higher spreading and elongation of cells seen in Fig. 9B. As previously reported, 
these cytoskeletal arrangements and changes in morphology are indicative of a shift towards an invasive pheno-
type46–49. Furthermore, specific morphology descriptors (Fig. 9C) including, aspect ratio (AR), circularity, and 
roundness, were calculated to divulge the effect of EGF on the cell shape. We limited the analysis to cells that were 
at the center of the z-stack to avoid the influence of attachment to the top and bottom of the chamber. The ARs of 
the cells, which indicated polarized length and extension, were significantly higher in (+ ) EGF (2.33 ± 0.14) than 
in (− ) EGF (1.75 ± 0.08). The extended morphology suggested that EGF played a role in enhancing the migra-
tory phenotype of the breast cancer cells30,50. Furthermore, the circularity of the cells within the EGF-stimulated 
devices was nearly half (0.25 ± 0.02) of the circularity for the (− ) EGF cells (0.53 ± 0.02). These findings suggested 
that the protrusiveness or cell extensions were much lower in unstimulated cells. Moreover, the roundness of the 
unstimulated cells was 0.66 ± 0.02 compared to 0.53 ± 0.02, which reflected the significantly higher amount of 
round cells for (− ) EGF demonstrated in Fig. 9A. Interestingly, the distribution of elongated cells were opposite 
Figure 6. Time-lapse analysis of individually invading cells within 24 h of adding EGF. (A) Dashed box 
indicates region of interest for time-lapse capture of cell invasion. Frames from a cell invasion movie where 
the cells are invading throughout the stroma toward the channels (scale bar: 100 μ m). (B) The cell trajectories 
were plotted. (C) (+ ) EGF cells demonstrated a significant increase in average cell speed but (D) no significant 
difference for persistence (p < 0.05 calculated from Student’s t-test with n > 50 from more than three devices for 
each condition). (E,F) The cells were filtered out for cells following the gradient (y-axis). We found significant 
increases in cell speed and persistence for (+ ) EGF (p  < 0.05 calculated from Student’s t-test with n > 25 from 
more than three devices for each condition).
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for the two conditions (Fig. 9D). Specifically, the ARs of the cells were binned into three different groups, high 
(AR > 2), medium (2 > AR > 1.5), and low (1.5 > AR). As can be seen in Fig. 9D, 55.8 ± 7.72% of (+ ) EGF cells 
were regarded as high, whereas only 25.2 ± 4.73% of (− ) EGF had high ARs. In contrast, (− ) EGF showed the 
enhanced low ARs and reduced high ARs. For the (− ) EGF condition, 59.6 ± 3.49% of the cells had low ARs in 
comparison to the 27.2 ± 6.13% of stimulated cells. There was no significant difference between the medium AR 
results. Furthermore, we examined the effect of (− ) EGF and (+ ) EGF on protrusiveness (Fig. 9E). On aver-
age, (+ ) EGF exhibited 3.94 ± 0.34 protrusions per cell whereas (− ) EGF demonstrated 1.36 ± 0.13 (Fig. 9F). 
Furthermore, the protrusion count per cell was compared with the aspect ratio and the circularity to determine 
the relationship between cell protrusion and cell morphology under the context of EGF stimulation. These results 
suggested that ARs and cell protrusions slightly correlated (R-squared = 0.11, p < 0.001) prior to EGF stimula-
tion, but upon introduction of EGF the correlation was negligible (R-squared = 0.00, p < 0.61). Furthermore, 
protrusions were correlated with circularity (Supplementary Fig. S7) indicating that under (− ) EGF condition, 
the circularity sharply decreased when cell protrusions increased. With EGF stimulation, circularity moderately 
declined (R-squared = 0.16, p < 0.001) with increasing cell extensions where the correlation was weaker than (− ) 
EGF condition (R-squared = 0.45, p < 0.0001). This result suggested that EGF stimulation reduced the correlation 
between circularity and cell protrusions similarly when looking at ARs and protrusions.
Further immunostaining, clearly demonstrated microtubule networks in both conditions (Fig. 10A). We also 
observed morphology changes between 3D stroma and 2D glass surface. In Fig. 10B, the red arrow indicates a 
cell migrating across the 2D plane while the yellow arrow indicates cells exiting the stroma. The morphology 
of the cells on 2D plane (Fig. 10B, red arrow) was distinctly different from that of the cells encapsulated within 
the 3D stroma (Fig. 10A and Supplementary Movies S4 and S5) showing that the device can recapitulate 2D 
and 3D morphologies51,52. The actin stress fibers (Fig. 10B, red arrow) spread across the relatively flat cell body 
with partial local alignment toward the direction of movement. Furthermore, the microtubules exhibited higher 
amount of fibers and polarization in the same direction. When observing the cells in the 3D stroma (Fig. 10A 
and Supplementary Movie S4 and S5), the cells were less spread, more spherical, and either with or without pro-
trusions. The cells within the stroma presented long protrusions reaching into the matrix whereas cells on the 
2D surface had short and flat protrusions (Supplementary Fig. S8, white and yellow arrow indicates protrusion 
and collagen stroma respectively, Supplementary Movie S6). Additionally, in Fig. 10B, the cells transitioning out 
of the matrix demonstrated a spherical cell body, similar to cells embedded within the 3D stroma. The flat short 
protrusions that were reaching out onto the 2D surface were characteristics of cells on glass substrate.
CAFs Enhance Breast Cancer Cell Invasion. To incorporate further complexities in the proposed tumor 
microenvironment, we investigated the invasive response of SUM-159 cells in the presence of CAFs (Fig. 11A). 
Figure 7. Time-lapse analysis of individually invading cells between 72 h and 96 h of EGF addition. (A) 
The cell trajectories were plotted. (B,C) (+ ) EGF cells demonstrated a significant increase in average cell speed 
and persistence (p < 0.05 calculated from Student’s t-test with n > 50 from more than three devices for each 
condition). (D,E) The cells were filtered out for cells following the gradient (y-axis). We found significant 
increases in cell speed and but no significant difference in persistence for (+ ) EGF (p  < 0.05 calculated from 
Student’s t-test with n > 9 from more than three devices for each condition).
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Specifically, we generated a tumor region comprised of SUM159 cells embedded in a 1:1 mixture of Matrigel® 
and collagen I (final concentration of collagen I at 1 mg/mL) and a surrounding stromal region consisting of 
100,000 cells/mL CAFs embedded in collagen I (2 mg/mL). In doing so, a 3D tumor-stroma arrangement of breast 
cancer cells and fibroblasts was successfully generated within the microfluidic device. Over the course of 3 days, 
SUM-159 cells expressing mCherry migrated into the surrounding stroma (Fig. 11B), where the presence of CAFs 
influenced the invasive profile of cancer cells (Fig. 11C). Specifically, CAFs induced higher invasion distance in 
SUM-159 cells (720 ± 15 μ m) as compared to the control condition (564 ± 12 μ m) containing no fibroblasts.
Discussion
Despite significant progress, the majority of microfluidic models lack cell and ECM spatial organization that 
allows for separate manipulation of side-by-side tumor and stromal regions to assess the roles of microenviron-
mental factors on 3D cancer invasion, in a real-time fashion25,26,28,53. For instance, work done by Sung et al.30,37 
provided 3D microenvironment models to spatially compartmentalize different cell types, however the overall 
objective of the work was not to assess real-time cancer cell invasion in 3D matrix. Additionally these models did 
Figure 8. Investigation of EGFR and pEGFR. (A) Cells were stained for EGFR (red), pEGFR (green), and 
nuclei (blue) (scale bar: 20 μ m). (B) Representative images of EGFR clusters with corresponding heat maps 
of relative intensities. (C) (+ ) EGF demonstrated significantly lower EGFR to cell area ratio. (D,E) (+ ) EGF 
displayed significantly higher pEGFR to cell area ratio and pEGFR to EGFR area ratio (p < 0.05 calculated from 
Student’s t-test with n > 18 from more than three devices for each condition).
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not incorporate perfusable channels surrounding the tumor-stroma regions to allow for diffusion of biomolecule 
gradients of chemotactic factors to the cells. Instead, their model was used to show differences in cell phenotype, 
which we also demonstrated in our platform. Furthermore, Kim et al.31, studied invasion in a 3D hydrogel but the 
model did not offer the ability to separately compartmentalize cancer cells and stromal ECM. Moreover, work by 
Zervantonakis et al.29,33,42, provided insight on the role of tumor-macrophage-endothelial interactions in invasion 
within a microfluidic tumor model, but was not designed to examine side-by-side arrangement of different 3D 
ECM components, which is crucial in understanding the invasion process. Our model enabled compartmental-
ization of tumor and stroma entities, which would allow for fine-tuning and control of heterogeneous ECM and 
cell components, as well as diffusive barriers (i.e. solid tumors) for nutrient and growth factor transport. Another 
contribution of our work was real-time high-resolution 3D invasion (in all x, y, z dimensions) and morphology 
studies at the single cell level.
Cancer cells were compartmentalized within our platform to represent a tumor surrounded by a stromal 
matrix (Fig. 1) where biochemical cues (i.e. EGF) diffused from outside of the stoma toward the center of the 
tumor region (Fig. 2). We primarily investigated the cell morphology and tensional homeostatic effect of encap-
sulating SUM-159 cells within three different matrices namely Matrigel® , collagen I, and 1:1 mixture of Matrigel® 
and collagen I (Fig. 3). Our analysis revealed that as the cells migrated and proliferated, they disrupted in the 
matrix either by proteolytic or tensional effect54 showing that either collagen I or Matrigel® matrix alone was una-
ble to maintain high fidelity of the tumor-stroma architecture. Furthermore, by mixing collagen I and Matrigel® 
(1:1 ratio), the combined matrix was able to support continuous migration (from tumor to stroma) and prolifer-
ation of the cancer cells with similar morphology compared to Matrigel® -only matrix. Collagen I was chosen for 
the surrounding stroma matrix where we demonstrated that the two matrices (i.e. Matrigel® :collagen I at 1:1 and 
collagen I) were not mixed but spatially organized as a stromal (collagen I) component surrounding the tumor 
region (Matrigel® :collagen I, Fig. 1). Such capability will enable addition of other cell types (i.e. CAFs) within 
Figure 9. Analysis of cell morphology. (A) Cells were stained for F-actin (green) and nuclei (blue). (− ) EGF 
exhibited more cells with round morphology (white arrows), which was correlated to a less invasive phenotype. 
(+ ) EGF appeared to be more protrusive (scale bar: 20 μ m). (B) Actin area calculated from thresholded images 
indicated higher quantities for (+ ) EGF after 4 days of culture. There was no significant difference between 
days 1 and 4 for (− ) EGF (P < 0.05 calculated from multiple comparisons test with more than three devices for 
each condition). (C) Cell shape descriptors of the actin-cytoskeleton were quantified using ImageJ software 
suite (particle analyzer plugin). (+ ) EGF had significantly higher aspect ratio (AR) and lower circularity and 
roundness; all of which correlate to a higher invasive phenotype (p < 0.05 calculated from Student’s t-test with 
n > 70 from more than three devices for each condition). (D) AR was reorganized into three categories, low: 
1 < AR < 1.5, medium: 1.5 < AR < 2.0, and high 2.0 < AR. Interestingly, (+ ) EGF contained significantly higher 
amounts of cells with high ARs whereas (− ) EGF contained significantly higher amounts of cells with low ARs. 
Both groups had no significant difference for the medium category (p < 0.05 calculated from Student’s t-test 
with n > 70 from more than three devices for each condition). (E) Protrusions (white star) were counted for 
each cell for the two conditions. (F) (+ ) EGF cells had significantly more protrusions than (− ) EGF (p  < 0.05 
calculated from Student’s t-test with n > 70 from more than three devices for each condition).
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the stroma region, which have been known to reduce chemoresistance37 as well as enhance tumor growth and 
invasion6.
We modulated the invasiveness of breast cancer cells by the introduction of a 3D EGF gradient within the 
tumor-stroma platform. The encapsulated breast cancer cells migrated (Supplementary Movie S1) in a radial 
direction outward from the 3D tumor region. EGF was found to heavily influence cell proliferation and inva-
sion distance to which by day 4, there were stark differences in tumor area coverage between the two studied 
conditions. The (+ ) EGF devices exhibited further invasion and increased transitioning from the 3D stroma to 
the surrounding media channels (Fig. 4). Moreover, we showed that addition of EGF increased invasion in the 
non-invasive cell line, MCF-7 (Supplementary Fig. S4). However when compared to SUM-159 cells, the level of 
Figure 10. 3D Analysis of F-actin and microtubules. (A) Fluorescent staining revealed cell morphology 
within the 3D matrix. Cells appeared to be round with slight protrusions. Microtubule fluorescence was intense 
in all directions for (− ) EGF, but had a slight affinity toward a single direction (white arrows) in the (+ ) EGF 
group. (B) Cell on 2D substrate appeared to be flat comprised of wide lamellipodia (red arrow). Cells moving 
toward the glass substrate had round cell body but large and wide protrusions (yellow arrow).
Figure 11. (A) Schematic of tumor cell and CAF interactions within the 3D platform. (B) SUM-159 cells 
expressing mCherry (red) invading into the stroma with or without CAFs, scale bar: 100 μ m. (C) Comparison of 
migration between SUM-159 only and SUM-159 + CAFs groups on day 3. (p  < 0.05 calculated from  
Student’s t-test with n > 6 devices for each condition).
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invasiveness of MCF-7 cells into the collagen stroma was almost 10-fold lower, demonstrating the ability of our 
platform to model the 3D migratory profile of a variety of cancer cell lines. Our platform also enabled creating 
differential microenvironments, specifically through introducing EGF in only one of the two segregated channels. 
SUM-159 cells were attracted to and demonstrated higher invasion to the EGF side (Fig. 5). Our findings were 
consistent with those from in vivo studies18,24 that demonstrated EGF enhanced invasion within mouse models. 
However, real-time high-resolution tracking of individual cells and visualization of 3D cell morphology were 
not possible using in vivo models18,38. Moreover, in previous microfluidic models31,33 that utilized EGF as a che-
moattractant, cell invasion characteristics were not fully captured within a 3D matrix in all x, y and z dimensions.
Our analysis of the real-time imaging (Supplementary Movies S2 and S3) revealed that the cells increased their 
individual motility in response to EGF, which confirms that the invasion of the stroma region was not limited to 
cell proliferation (Fig. 4D) but also included chemokinesis (Figs 6 and 7). We found that during the initial 24 h, 
the whole cell population responded to EGF with increased motility but the overall persistence was not signifi-
cant. However, when looking only at the filtered cells migrating along the gradient (y-axis) (Fig. 6D,E), we found 
significant increases for individual cell motility and persistence in (+ ) EGF condition. As expected, there was no 
difference in persistence for (− ) EGF for the whole population of cells as well as the filtered cells (Supplementary 
Fig. S9). This suggests that the population of cells may be heterogeneous in that sub-populations respond to EGF 
differently55. Therefore, by analyzing chemotactic responses based on population averages, the end results may 
fail to account for the aggressive sub-population that can contribute the most to invasion56. For longer times (after 
72 h), there was no significant difference in persistence toward the gradient (Fig. 7E) which overall appeared to 
be more of a random walk. This suggests that over saturation of EGF (72 h) may prolong the overall persistence 
regardless of the direction (Fig. 7C). Moreover, it has been noted in studies utilizing 2D platforms that EGF treat-
ment induces internalization of EGFRs through endocytosis44,57 to regulate processes such as cell migration45. 
The data presented here (Fig. 8 and Supplementary Fig. S6) demonstrate that our 3D model reiterates the current 
understanding of EGFR trafficking in 2D after activation with EGF. In addition, several studies have indicated 
that prolonged exposure to EGF, such as in our investigation, will internalize or localize clusters of EGFRs thus 
reducing the amount of surface EGFRs44,58 (Fig. 8). However, none of the previous studies showed prolonged loss 
of 3D chemotactic responses (i.e. persistence toward the gradient), despite ongoing chemokinesis (i.e. cell speed) 
in the later stages of invasion, which may be due to saturation of EGFRs25,26,31,44,45,57. This could be a potential area 
of study to investigate the prolonged spatiotemporal signaling of EGF, in relation to chemokinetic and chemot-
actic responses, in cancer cells.
Cell morphology analysis, indicated that cells migrating on the glass appeared to have flat and wide pro-
trusions resembling lamellipodia. These cells (Supplementary Movie S7) appeared to follow the characteristic 
migration steps, which are the exploration and then attachment of the leading edge followed by the detach-
ment and pulling of the rear cell body59. On the other hand, within 3D matrix, the cells did not clearly exhibit 
the classical stages of migration51 but instead appeared to entangle inside the matrix with the thin-like protru-
sions (Supplementary Movie S2), which induced a slow moving crawl. Similarly, F-actin staining of the encapsu-
lated cells (Supplementary Fig. S3) revealed thin protrusions surrounding the cell body correlating to what was 
observed in the migrating cells (Supplementary Movie S2). Consistently, Lämmermann et al. demonstrated elon-
gation and dragging of the cell body, hypothesized that this phenomenon happened in areas of increased spacing 
between collagen fibers60. Similarly to the results found with our device, Fraley et al. showed several protrusions 
extending from migrating cells in 3D matrices but did not show wide lamellipodia in 3D. Furthermore, they sug-
gested that the cells utilized these protrusions to probe the surrounding matrix which led to correlating the extent 
and amount of protrusions to cell motility in 3D61. We further observed noticeable deformation of the collagen 
matrix overtime in the device, which was the driving factor to producing a suitable matrix composition for the 
encapsulation of the invasive cancer cells. When closely observing the migrating cells, there were some cells that 
tended to follow in the tracks of another cell. This observation was in line with previous work by Gaggioli et al. 
who studied invasion inducing-microtracks62. This behavior would require further analysis to elucidate the mech-
anisms of this migratory phenotype.
Stromal cells, such as fibroblasts, endothelial cells, and immune cells, have been demonstrated to heavily 
influence cancer invasion and therapy38,63. In particular, CAFs have been shown to enhance cancer survival and 
invasion through cell-cell signaling63. In our model, we showed that in the presence of CAFs, SUM-159 cells 
migrated further into the surrounding stromal region compared to the control condition (no CAFs) (Fig. 11C). 
Based on previous literature and our own experiments, we believe that CAFs are potentially secreting chemoat-
tractants64 such as stromal cell-derived factor 1α (SDF-1α or CXCL12) that promote breast cancer invasion. This 
phenomenon creates a unique opportunity for future studies to mechanistically assess the influence of paracrine 
signaling and the resulting effects within a heterogeneous population of cells on cancer invasion using our pro-
posed platform.
Taken together, our microfluidic platform demonstrated the capability of studying tumor growth and can-
cer cell migration at a single cell level with the advantage of direct control over spatial cell-ECM, cell-cell and 
cell-ligand interactions. In our future studies, we aim to incorporate stromal cells (i.e. cancer associated fibro-
blasts) surrounding the tumor region for more physiologically relevant invasion studies.
Conclusions
In this work, a new 3D microfluidic platform, designed with separate tumor-stroma entities, was developed to 
recapitulate 3D cancer cell invasion. Our platform enabled, precise control over cell-ECM and cell-growth fac-
tor interactions. We specifically investigated the invasion enhancing effects of EGF and validated the platform 
as a real-time functional assay for fundamental biological processes (i.e. cell invasion, cellular signaling). Our 
unique approach allowed for visualization and quantification of invasion and morphology changes, at a single cell 
level, which was not possible in conventional Transwell assays, 3D macroscale hydrogels, and animal models. We 
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spatially organized a high density of SUM-159 breast cancer cells within a confined 3D tumor region composed 
of Matrigel® and collagen type I. A stromal matrix of collagen type I surrounded the tumor region, which allowed 
diffusion of EGF through the stroma into the primary tumor. On a global level, we observed enhanced invasive-
ness of the breast cancer tumor front when stimulated with EGF. At a single-cell level, we performed real-time 3D 
migration, which confirmed the increased motility and persistence of cells due to EGF stimulation. Moreover, we 
showed changes in persistence and migration at different time frames, where we observed that initially a subset 
of cells migrated preferentially toward the gradient. However, after prolonged exposure to EGF, we found no dif-
ference in persistence between the EGF condition and the control despite still increasing cell motility due to EGF. 
Subsequently, we found higher EGFR clustering within the cell after 4 days of EGF exposure suggesting possible 
receptor saturation44,58, which could explain the lowered chemotactic responses at later time points. We observed 
cytoskeletal and morphological changes in the EGF-stimulated devices, where the cells demonstrated a more 
invasive phenotype (i.e. increased aspect ratio and reduced circularity) with higher protrusion counts. Lastly, we 
investigated the co-culture of SUM-159 cells and CAFs within the tumor and stroma region respectively, which 
resulted in enhanced SUM-159 invasion. Together, this demonstrates the ability of our device to visually observe 
a combination of cell migration, morphology, survival, and proliferation changes, which provides a valuable tool 
that recapitulates 3D tumor-stroma interaction and invasion in a single platform.
Our future studies will be focused on adding complexities to this process by studying heterotypic cell inter-
actions, such as the investigating the diverse roles of CAFs within a 3D stromal region. We further plan to take 
advantage of our device to investigate and image real-time changes in cell morphology and migration under dif-
ferent therapeutics regimens such as suberoylanilide hydroxamic acid49, nocodazole48, paclitaxel65, etc. Moreover, 
we aim to manipulate the cell-cell interactions to study how the heterotypic dialogue affects drug resistance.
Materials and Methods
Microfluidic design and fabrication. The microfluidic platform was fabricated using photo- and soft-li-
thography techniques. First, the design was created utilizing cad software, and subsequently, a transparent mask 
was fabricated from this design to undergo SU-8 photolithography. SU8-2075 (MicroChem) was spun onto a 
silicon wafer with a height of 200 μ m. Next, the wafer was placed underneath the transparent mask and exposed 
to UV to generate the mold for the microfluidic device. Polydimethylsiloxane (PDMS, Sylgard 184 Silicon 
Elastomer Kit, Dow Corning) was casted over the SU-8 wafer and baked for 1 h at 80 °C. Afterwards, the PDMS 
was peeled off and the devices were cut out with blades, and afterwards, the inlets and outlets were cored using 
biopsy punches. Next, these devices were treated with oxygen plasma (PDC-32G, Harrick Plasma) and were then 
bonded to glass with channel side facing down to create a sealed environment. The fabricated microfluidic chips 
were sterilized by wet autoclave followed by a dry autoclave. The chips were surface treated by injecting 1 mg/mL 
poly-d-lysine (PDL, Sigma-Aldrich) into the channels and chambers. The devices were incubated at 37 °C for 1 h 
and then washed with deionized (DI) water. Next, 0.1% (v/v) glutaraldehyde (GA, Sigma-Aldrich) solution was 
added into the channels and chambers and incubated at room temperature for 1.5 h. Finally, the devices were 
washed 4 times with DI water and placed in an 80 °C oven overnight to render the surfaces hydrophobic.
Diffusion across the tumor-stroma. COMSOL simulation of EGF diffusion was used to characterize and 
predict the time-dependent gradient within the platform. Diffusion occurs primarily in the x-y plane due to the 
fact that the imposed concentrations in the channels are independent of z, there is no flux through the top and 
bottom surfaces, and the geometry is uniform in z. Thus, EGF was uniformly distributed in the z-direction aside 
from small variations due to the distribution of cells within the gel regions. Note also that the diffusion coefficient 
of collagen is relatively constant in all directions within the hydrogel so there should be no major change in diffu-
sion influenced in the z direction of the hydrogel. Therefore, we utilized a two-dimensional model to simulate 
diffusion of EGF in one x-y plane of the 3D device. Based on Stokes-Einstein piη=D kT R/6c  relationship66, where 
k is the Boltzmann constant (1.38 × 10−23 J • K−1), T  = 298.15 K, R is the Stokes radius (23 angstroms), and η is the 
dynamic viscosity of the media (0.78 × 10−3 N • s/m2)67, the diffusion coefficient for a 10 kDa molecule within 
media at 37 °C was calculated to be 9.25 × 10−11 m2/s. The coefficient for the 3D collagen I gel (2.0 mg/mL) was 
determined to be 8.7 × 10−11 m2/s by multiplying the media coefficient by the diffusion hindrance coefficient 0.94 
(i.e. diffusion through the gel compared to the solution). This value is predicted based on the area fraction of 
collagen related to the fiber diameter of isotropic fiber networks. The pores (> 0.75 μ m for collagen area fraction 
of less than 1%)68 within the collagen hydrogel being larger than the hydrodynamic radius of the dextrans33,68 
resulted in approximate diffusion hindrance to be 0.94 based on work done by Stylianopoulos et al. Inlet was set 
to zero flow, the outlet was set to zero pressure, the concentration of the molecule within the channels was set 
equal to 10 μ g/mL, and the inlet concentrations were set constant at 10 μ g/mL.
Fluorescent dextran (10 kDa FITC-Dextran (10 μ g/mL)) was injected into the media inlets and the resulting 
fluorescent intensity across the platform was recorded over time for 2 h every 5 min. Relative intensity of the con-
centration gradient was quantified in ImageJ by using the profile tool.
Cell culture. SUM-159 breast cancer cells was chosen as a suitable cell type to invade through a 3D hydrogel69. 
The MCF-7, SUM-159 and mCherry-labeled SUM-159 breast cancer cells, provided by the Mouneimne lab, were 
cultured in MCF-7 specific media (Dulbecco’s Modified Eagle Medium supplemented with 10% heat inactivated 
fetal bovine serum (FBS), 1x penicillin-streptomyocin) and SUM specific media (Ham’s F-12 with L-glutamine 
and supplemented with 5% heat inactivated fetal bovine serum (FBS), 1x penicillin-streptomyocin, 1 μ g/ml 
hydrocortisone, and 5 μ g/ml insulin) respectively. CAFs (passage > 55) were acquired from ATCC (ATCC® HTB 
125™ ) and cultured in MCF-7 specific media. The cells were maintained within a humidified cell culture incuba-
tor at 37 °C and 5% CO2.
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Invasion assay. To load the cancer cells into the device for invasion experiments, cells were trypsinized and 
pelleted into 0.5 mL microcentrifuge tubes. Matrigel® (Corning), collagen I (2.0mg/mL, Corning® Collagen I, Rat 
Tail, 100mg, Product #354236, Corning) and a 1:1 mixture of Matrigel® to collagen type I (2.0 mg/mL) was added 
to the cells to create a mixed hydrogel cell solution (final concentration of collagen I at 1 mg/mL) with a density of 
15 million cells/mL. We optimized the cell density ranging from 1 million/mL to 40 million/mL in order to create 
a dense solid tumor (estimated to be 50 to 400 million/mL from xenografts)70,71. The preliminary optimization 
indicated that lower densities (5 million/mL) did not allow us to obtain a good sufficient population of migrating 
cells within the first 4 days of experiment for subsequent analysis. The mixed hydrogel cell solution was injected 
into the tumor region of the microfluidic chip and polymerized by placing the devices into the humidified cell 
culture incubator at 37 °C. These chips were flipped every 1 min to create a homogenous distribution of cells 
within the mixed gel. After 8 min within the incubator, the devices were taken out and subsequently a 2.0 mg/mL 
collagen type I solution was injected into the stromal region. For co-culture with CAFs, 100,000 cells/mL were 
encapsulated in the collagen type I solution. The collagen was polymerized within the humidified incubator at 
37 °C for 8 min. Next, SUM media was added into the channels of each device and the microfluidic chips were 
placed into the cell culture incubator overnight. On the next day, the media within EGF-stimulated devices ((+ ) 
EGF) was exchanged with SUM media supplemented with EGF (50 ng/mL). Unstimulated devices ((− ) EGF) 
were based on the use of normal SUM media. Media was changed daily for the whole culture period.
Phase-contrast images of the cells were acquired once every day using 4 × 3 tiles with a 10x objective. 
Distribution of invading cells was quantified from these images by measuring the distance from the cells to the 
nearest micropost. If there was a cell in a cluster, only the furthest point on the furthest cell from that cluster was 
measured unless clear cell borders were distinguishable. Each measurement was taken from the most distal pro-
trusion of the cell (not the cell body). To quantify the invading edge of the tumor (i.e. the invading tumor front), 
only the cells on the periphery were measured by considering the most distal points of the most distal cells. In this 
case, only the cells at the edge of the tumor (i.e. cells that have traveled the highest distance from the tumor region 
from each degree) were included in the quantification.
To perform time-lapse imaging, mCherry-labeled SUM-159 cells were mixed together with normal SUM-
159 at a ratio of 1:9 prior to the invasion assay. The devices were placed inside a custom miniature incubator 
(TC-MWP, Bioscience Tools) with a 4-well insert, which enabled imaging of 4 devices at a time at 37 °C and 5% 
CO2. Fluorescent time-lapse imaging was performed using a fluorescent microscope (Zeiss Axio Observer Z1, 
Zeiss) equipped with the Apotome.2 and a 10x objective. The z-resolution and the time interval were set to 3.45 μ m 
and 45 min, respectively. 3D time-lapse images were taken within 24 h of adding EGF and between days 3 and 4 
of the invasion assay. Speed (defined as distance over time) and persistence (defined as euclidean distance over 
accumulated distance) were utilized to quantify cell migration metrics. To filter out the cells to obtain those that 
migrate toward the gradient, the average angles of each cell trajectory were compiled and reduced to those cells 
within ± 30° of the y-axis (i.e. the direction of the gradient).
Fluorescent staining. For immunofluorescent (IF) staining, the cells were fixed by adding warmed 4% par-
aformaldehyde into the channels of the microfluidic chip for 30 min. The devices were then washed twice with 
PBS-glycine (100 mM glycine in PBS) for 10 min at room temperature. This was followed by a single wash using 
PBS-Tween (0.05% (v/v) Tween-20 in PBS). Next, IF buffer (0.2% (v/v) Triton X-100 + 0.1% (v/v) BSA (radi-
oimmunoassay grade) + 0.05% Tween 20, 7.7 mM NaN3 in PBS) + 10% (v/v) goat serum was added into the 
channels and the devices were incubated at room temperature for 1.5 h. Later, primary antibodies, monoclonal 
Anti-α -Tubulin (1:500, T9026, Sigma-Aldrich), Ki-67 (1:100, (DSHB Hybridoma Product AFFN-KI67-3E6)), 
EGFR (1:1000, MA5-13319, Thermo Scientific), or pEGFR (1:100, 3777S, Cell Signaling Technology® ) were 
diluted at in IF buffer and devices were parafilmed and kept at 4 °C overnight. Afterwards, the microfluidic chan-
nels were washed 3 times utilizing IF buffer for 20 min each. Then, the secondary antibody (Alexa Fluor® 488, 
555, or 647, Thermo Fisher Scientific) was diluted in IF buffer for 45 min at room temperature in the dark. The 
devices were washed once with IF buffer for 20 min and twice with PBS-Tween for 10 min each at room temper-
ature. Afterwards, the nuclei and F-actin fibers were stained by using 4′ ,6-diamidino-2-phenylindole (DAPI, 
Invitrogen) (1:1000) and Alexa Fluor® 488 Phalloidin (Invitrogen) (1:40) overnight at 4 °C. The dilutions were 
done using PBS-Tween. Finally, the devices were washed 5 times in PBS-tween for 10 min each before imaging.
Imaging and analysis. All imaging was performed using a Zeiss Axio Observer Z1 with the Zen Pro software 
suite. Phase-contrast images of the invasion assay were captured using a 10x objective lens. Immunofluorescent 
images were taken with 10x and 40x objective lenses together with the Apotome.2 (Zeiss). The Apotome.2 created 
optical sections of our devices, reducing scattered light, to generate clear fluorescent z-stacked images for 3D 
images.
To quantify cell proliferation, cells expressing mCherry were counted on days 1 and 3 and compared. 
Moreover, Ki-67 proliferative marker was also quantified by comparing the cells expressing Ki-67 to total cell 
population. The index was developed by dividing Ki-67 positive cells by all nuclei within a field of view (40x 
magnification, 223 × 167 μ m2).
To analyze EGFRs and pEGFRs on days 2 and 4, we thresholded images (40x magnification) of the receptors 
in ImageJ with actin for their respective coverage areas. EGFR and pEGFR areas were divided by the area of the 
cell body resulting in a normalized ratio. We also divided the pEGFR area by the EGFR area to analyze the phos-
phorylated receptors among the non-phosphorylated ones. Heat maps were created using the 3D surface plot 
plugin in ImageJ.
To investigate the cytoskeletal organization of the cells, we looked at the actin area, cell shape, and protrusive-
ness. The actin fibers were thresholded in ImageJ producing an area value based on the number of pixels repre-
senting the F-actin fiber coverage area. Subsequently, this area was divided by the cell total count (nuclei) in the 
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field of view (20x magnification, 0.45 × 0.34 mm2) on days 1 and 4 of culture. We used the particle analyzer plugin 
within the ImageJ suite to further quantify cell shape (i.e. aspect ratio, circularity, and roundness) based on the 
actin masks. Finally, the protrusions of the cells were manually counted in the actin cytoskeleton by quantifying 
the number of extensions (> 3 μ m in length and 1 μ m in width) from the cell body.
Statistical analysis. All measurements were compiled from three or more independent devices for each 
experimental condition. The data were compared using unpaired Student’s t-tests, multiple comparisons tests, and 
correlation analysis within the GraphPad Prism software (GraphPad Prism 6 Software).
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